Replicating human brain function in vitro for finding cures for human brain dysfunction.

Provides innovative services to pharmaceutical and biotech companies, by creating functional human brain cells and integrating them with sensor chips to uncover drug effects on brain function that traditional methods cannot detect.

The company strives to create a future where the impact of every drug on human brain function is fully understood before it reaches patients.

Impact: By providing deeper insights into the effects of pharmaceuticals on the human brain, the company contributes to safer, more effective treatments while reducing the reliance on animal testing. This ultimately leads to improved patient outcomes and a more ethical approach to drug discovery.

Adressing United Nations Sustainable Development Goal (SDG): Goal 3 - Good Health and Well-being.

CEO: Sebastian Illes
GUV Contact: Jesper Dahlberg